| Literature DB >> 35665762 |
Areum Jeong1,2, Xue Yao1,2, Jano van Hemert3, Min Sagong4,5.
Abstract
Diabetic retinopathy (DR) is characterized by microvascular changes including ischemia. Degradation and metabolic changes of various retinal cells occur during ischemia. Ischemic region containing more cells will lead to greater metabolic impairment. We analyzed the non-perfusion region (NPR) by integrating histologic mapping with ultra-widefield fluorescein angiography (UWF FA) images. We also investigated the correlations of the weighted ischemic index (ISI) considering the regional distribution of retinal cells with cytokines, macular edema (ME), and neovascularization (NV). In this study, 32 patients with treatment-naïve DR and 21 age-matched control participants were included. The difference between the non-weighted and weighted ISI of NPR with leakage was greatest at the posterior region. The weighted ISI of NPR with leakage was correlated with MCP-1, IL-8, IL-6, PlGF, and VEGF-A levels, while the non-weighted ISI of NPR with leakage was correlated with IL-8 and IL-6 levels. The presence of baseline ME or NV in patients with DR was associated with the weighted ISI, with a stronger association when cones and rods were weighted. The weighted ISI reflecting both metabolic activity and cell distribution demonstrated a better correlation with clinical features and was more valuable in NPR with leakage than non-weighted ISI, which previous studies conventionally used.Entities:
Mesh:
Substances:
Year: 2022 PMID: 35665762 PMCID: PMC9167306 DOI: 10.1038/s41598-022-13439-z
Source DB: PubMed Journal: Sci Rep ISSN: 2045-2322 Impact factor: 4.996
Patient characteristics, demographics, clinical features, and cytokine levels.
| Demographic features | DR (n = 32) | Control (n = 21) | |
|---|---|---|---|
| Age, years; mean ± SD | 63.6 ± 10.2 | 64.3 ± 7.9 | 0.860* |
| 0.783† | |||
| Male | 13 (40.6) | 8 (38.1) | |
| Female | 19 (59.4) | 13 (61.9) | |
| Mild NPDR | 0 | ||
| Moderate NPDR | 0 | ||
| Severe NPDR | 9 (28.1) | ||
| PDR | 23 (71.9) | ||
| Diabetes duration, years; mean ± SD | 7.8 ± 6.2 | ||
| Spherical equivalent, diopters; mean ± SD | − 0.07 ± 0.91 | − 0.32 ± 0.93 | 0.087* |
| BCVA, logMAR; mean ± SD | 0.56 ± 0.32 | 0.35 ± 0.37 | 0.025* |
| CMT, μm; mean ± SD | 447.3 ± 135.2 | 263.9 ± 13.6 | < 0.001* |
| Presence of ME | 27 (84.4) | ||
| Presence of NV | 23 (71.9) | ||
| Non-weighted ISI | 0.49 ± 0.20 | ||
| Weighted ISI | 0.41 ± 0.17 | ||
| Ang-1 | 122.91 ± 437.21 | 35.08 ± 36.59 | 0.041* |
| Ang-2 | 412.21 ± 1417.98 | 27.53 ± 36.88 | 0.029* |
| MCP-1 | 942.49 ± 1080.65 | 646.55 ± 247.83 | 0.002* |
| IL-8 | 56.70 ± 158.77 | 12.05 ± 10.23 | < 0.001* |
| IL-6 | 50.21 ± 167.23 | 3.98 ± 5.74 | < 0.001 |
| PDGF-AA | 61.62 ± 183.89 | 24.94 ± 7.92 | 0.186 |
| PlGF | 32.95 ± 120.27 | 0.71 ± 0.50 | 0.012* |
| VEGF-A | 244.41 ± 323.82 | 57.64 ± 22.48 | < 0.001* |
BCVA best-corrected visual acuity, DR diabetic retinopathy, CMT central macular thickness, ISI ischemic index, logMAR logarithm of the minimum angle of resolution, ME macular edema, NPDR non-proliferative diabetic retinopathy, NV neovascularization, PDR proliferative diabetic retinopathy, SD standard deviation,
*Mann–Whitney U test.
†Chi-square test.
Figure 1The distributions of weighted and non-weighted ischemic index (ISI) of nonperfusion region (NPR) with leakage among retinal zones.
Figure 2Correlations of the ischemic index (ISI) of NPR with leakage with the central macular thickness (CMT) and aqueous cytokine levels. While the weighted ISI of NPR with leakage had a significant positive correlation with CMT, levels of monocyte chemoattractant protein (MCP)-1, placental growth factor (PlGF), and vascular endothelial growth factor (VEGF)-A, the non-weighted ISI of NPR with leakage showed no significant correlation with them.
Correlations of weighted and non-weighted ISI with visual acuity, central macular thickness, and levels of cytokines.
| BCVA | CMT | Ang-1 | Ang-2 | MCP-1 | IL-8 | IL-6 | PDGF-AA | PlGF | VEGF-A | |||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| R | R | R | R | R | R | R | R | R | R | |||||||||||
| Non-weighted | 0.242 | 0.680 | 0.284 | 0.127 | − 0.052 | 0.468 | 0.068 | 0.321 | 0.345 | 0.065 | 0.284 | 0.041* | 0.218 | 0.039* | 0.045 | 0.874 | 0.380 | 0.674 | 0.340 | 0.173 |
| Weighted ISI | 0.319 | 0.472 | 0.485 | 0.040* | 0.179 | 0.352 | 0.372 | 0.051 | 0.456 | 0.034* | 0.448 | 0.010* | 0.336 | 0.018* | 0.312 | 0.287 | 0.481 | 0.012* | 0.574 | 0.010* |
| Cone | 0.428 | 0.011* | 0.447 | 0.038* | − 0.062 | 0.667 | 0.148 | 0.144 | 0.431 | 0.041* | 0.369 | 0.020* | 0.304 | 0.034* | 0.287 | 0.191 | 0.429 | 0.040* | 0.519 | 0.038* |
| Rod | 0.226 | 0.020* | 0.421 | 0.025* | 0.146 | 0.479 | 0.279 | 0.056 | 0.470 | 0.023* | 0.453 | 0.015* | 0.413 | 0.029* | 0.349 | 0.078 | 0.478 | 0.008* | 0.542 | 0.012* |
| Ganglion cell | 0.116 | 0.132 | 0.163 | 0.411 | 0.532 | 0.243 | 0.367 | 0.068 | 0.242 | 0.062 | 0.217 | 0.124 | 0.147 | 0.104 | 0.227 | 0.412 | 0.347 | 0.054 | 0.223 | 0.060 |
| Non-weighted | 0.121 | 0.655 | 0.175 | 0.346 | − 0.062 | 0.436 | − 0.075 | 0.524 | − 0.068 | 0.512 | 0.255 | 0.063 | 0.195 | 0.057 | − 0.012 | 0.823 | − 0.064 | 0.453 | − 0.120 | 0.487 |
| Weighted ISI | 0.124 | 0.438 | 0.136 | 0.464 | − 0.126 | 0.418 | − 0.032 | 0.893 | − 0.052 | 0.776 | 0.282 | 0.038* | 0.273 | 0.020* | − 0.020 | 0.673 | 0.057 | 0.566 | 0.023 | 0.840 |
| Cone | 0.156 | 0.345 | 0.140 | 0.982 | − 0.174 | 0.325 | − 0.115 | 0.562 | 0.061 | 0.715 | 0.262 | 0.041* | 0.263 | 0.010* | 0.325 | 0.434 | 0.113 | 0.693 | 0.210 | 0.462 |
| Rod | 0.085 | 0.636 | 0.184 | 0.770 | − 0.112 | 0.513 | 0.043 | 0.648 | 0.043 | 0.766 | 0.303 | 0.030* | 0.324 | 0.026* | − 0.132 | 0.731 | 0.179 | 0.284 | 0.078 | 0.645 |
| Ganglion cell | 0.047 | 0.647 | 0.097 | 0.612 | − 0.131 | 0.332 | 0.074 | 0.577 | 0.052 | 0.734 | 0.145 | 0.632 | − 0.179 | 0.346 | − 0.064 | 0.695 | 0.086 | 0.513 | 0.034 | 0.742 |
P-values were calculated using Spearman correlation.
BCVA best-corrected visual acuity, CMT central macular thickness, ISI ischemic index, R Spearman correlation coefficient.
*P < 0.05.
Associations of baseline characteristics with weighted and non-weighted ISI of nonperfusion with leakage.
| Confounding factor | ISI | Coefficient | |
|---|---|---|---|
| BCVA (logMAR) | Non-weighted ISI | 2.64 | 0.481 |
| Total | 3.29 | 0.313 | |
| Cone | 2.32 | 0.264 | |
| Rod | 4.45 | 0.153 | |
| Ganglion cell | -0.18 | 0.821 | |
| ME at baseline (yes/no) | Non-weighted ISI | 1.59 | 0.142 |
| Total | 3.80 | 0.045 | |
| Cone | 3.64 | 0.036 | |
| Rod | 4.19 | 0.029 | |
| Ganglion cell | 0.09 | 0.085 | |
| NV at baseline (yes/no) | Non-weighted ISI | 4.77 | 0.127 |
| Total | 8.70 | 0.044 | |
| Cone | 10.48 | 0.035 | |
| Rod | 14.82 | 0.012 | |
| Ganglion cell | 1.50 | 0.117 | |
P-values were calculated using multiple linear regression analysis.
*P < 0.05.
Figure 3Metabolic quantification of ultra-widefield fluorescein angiography (UWF FA) image. (A) Shows an UWF FA image with annotation of the nonperfusion region with leakage overlaid in green. (B) Shows the ganglion cell density map overlayed on the same UWF FA image with a density scale in cells per square millimeter. The estimated number of affected ganglion cells of 1 pixel is calculated by multiplying the size of that pixel on the retina in square millimeters with the ganglion cell density of the corresponding pixel in (B) in cells per square millimeters. The total number of affected ganglion cells in the annotated area (green) in (A) is the sum of these multiplications for all pixel parts of the annotated area (green) in (A). (C) shows the rod photoreceptor density map and (D) shows the cone photoreceptor density map overlayed on the same UWF FA image.